Clinical Trial Update: Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating DNA vaccines for genital herpes caused by HSV-2; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes
• Genital Herpes Simplex Type 2

Drugs mentioned

• DNA vaccines to Treat Genital Herpes (unspecified compound names)

Snippet

Sponsor: Vical | Conditions: Genital Herpes Simplex Type 2 | Phase 1, Phase 2 | Status: COMPLETED